Trimebutine Maleate

马来酸曲美布汀

Report date: 2026/02/25 20:02:36
NME

Base Information

Drug NameTrimebutine Maleate
Drug Alias Name三甲丁马来酸酯曲美布汀马来酸盐马来酸三甲氧苯丁氨酯援生力维Modulon SR +[11] 
ClassificationSmall molecules
Mechanisms of ActionOpioid receptors agonistsMuscarinic acetylcholine receptor antagonists
TargetsOpioid receptorsMuscarinic acetylcholine receptor
Therapy Area/IndicationsAbdominal PainIrritable Bowel SyndromeGastritis +[8] 
Global Approved IndicationsIrritable Bowel SyndromeGastritisGastrointestinal Diseases
Approved Indications in ChinaIrritable Bowel SyndromeGastrointestinal Diseases
Original Approved Country/TerritoryJapan
Original Approved Date1984/02/15
Country/TerritoryMexicoRussian FederationArgentina +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of ColimaMitsubishi Tanabe PharmaKaikai Yuansheng Pharmaceutical Co Ltd +[4] 
Inactive CompaniesHospital Britanco
Active IndicationsAbdominal PainIrritable Bowel SyndromeGastritis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeA03AA05
Related LinksWikipediaDrugBankKEGG